Atlas Trials

Gallbladder Adenocarcinoma

9 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Gallbladder Adenocarcinoma

RecordFirmDate
Safety and Feasibility of HIPEC for High-Risk Gallbladder Adenocarcinoma (NCT05430035)West Virginia University2022-06-23
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels (NCT04931420)University of Chicago2022-05-19
Study of PEGPH20 With Cisplatin (CIS) and Gemcitabine (GEM); PEGPH20 With Atezolizumab (ATEZO), CIS, and GEM; and CIS and GEM Alone in Participants With Previously Untreated, Unresectable, Locally Advanced, or Metastatic Intrahepatic and Extrahepatic Cholangiocarcinoma and Gallbladder Adenocarcinoma (NCT03267940)Halozyme Therapeutics2017-10-02
ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer (NCT01825603)University of Nebraska2013-04-09
Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma (NCT01093222)National Cancer Institute (NCI)2010-04-01
Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder Cancer (NCT00361231)Massachusetts General Hospital2006-05-01
Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer (NCT00142480)Massachusetts General Hospital2004-12-01

Track Gallbladder Adenocarcinoma automatically

Every clearance here is in the API, with alerts when new ones post.